期刊
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
卷 313, 期 6, 页码 E663-E671出版社
AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpendo.00168.2017
关键词
fasting glucose; interleukins; soluble receptors
资金
- Blavatnik Biomedical Accelerator of Harvard University
- National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant (NHLBI) [R01-HL-117986]
- NIH National Institute on Aging Grant [R01-AG-047131.1]
- EMBO
- Israel Scholarship Education Foundation (ISEF) Fellowship
- NHLBI [R01-HL-080978]
- National Space Biomedical Research Institute [HPF 00402]
- NIH [M01-RR-02635]
- Harvard Catalyst-The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, NIH) [UL1-TR-001102]
- Brigham and Women's Hospital
- Harvard University
Soluble IL-13 receptor-alpha 1, or sIL13r alpha 1, is a soluble protein that binds lo interleukin-13 (IL-13) that has been previously described in mice. The function of sIL13r alpha 1 remains unclear, but it has been hypothesized to act as a decoy receptor for IL-13. Recent studies have identified a role for IL-13 in glucose metabolism, suggesting that a decoy receptor for IL-13 might increase circulating glucose levels. Here, we report that delivery of sIL13r alpha 1 to mice by either gene transfer or recombinant protein decreases blood glucose levels. Surprisingly, the glucose-lowering effect of sIL13r alpha 1 was preserved in mice lacking IL-13, demonstrating that IL-13 was not required for the effect. In contrast, deletion of IL-4 in mice eliminated the hypoglycemic effect of sIL13r alpha 1. In humans, endogenous blood levels of IL13r alpha 1 varied substantially, although there were no differences between diabetic and nondiabetic patients. There was no circadian variation of sIL13r alpha 1 in normal human volunteers. Delivery of sIL13r alpha 1 fused to a fragment crystal-lizable (He) domain provided sustained glucose lowering in mice on a high-fat diet, suggesting a potential therapeutic strategy. These data reveal sIL13r alpha 1 as a circulating human protein with an unexpected role in glucose metabolism.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据